Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Nirav N. Shah, MD, Medical College of Wisconsin, Brookfield, WI, discusses the next steps in the treatment of non-Hodgkin lymphoma (NHL), in particular commenting on the need for more precise treatments and optimization of therapy combinations. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
Disclosures
Nirav N. Shah, MD, has participated in consultancy work and advisory board with Lily Pharmaceuticals.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.